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Silver is an ancient antibiotic that has found many new uses due to its unique properties
on the nanoscale. Due to its presence in many consumer products, the toxicity of nano-
silver has become a hot topic. This review summarizes recent advances, particularly the
molecular mechanism of nanosilver toxicity. The surface of nanosilver can easily be
oxidized by O2 and other molecules in the environmental and biological systems leading to
the release of Agþ, a known toxic ion. Therefore, nanosilver toxicity is closely related to the
release of Agþ. In fact, it is difficult to determine what portion of the toxicity is from the
nano-form and what is from the ionic form. The surface oxidation rate is closely related to
the nanosilver surface coating, coexisting molecules, especially thiol-containing com-
pounds, lighting conditions, and the interaction of nanosilver with nucleic acids, lipid
molecules, and proteins in a biological system. Nanosilver has been shown to penetrate the
cell and become internalized. Thus, nanosilver often acts as a source of Agþ inside the cell.
One of the main mechanisms of toxicity is that it causes oxidative stress through the
generation of reactive oxygen species and causes damage to cellular components including
DNA damage, activation of antioxidant enzymes, depletion of antioxidant molecules (e.g.,
glutathione), binding and disabling of proteins, and damage to the cell membrane. Several
major questions remain to be answered: (1) the toxic contribution from the ionic form
versus the nano-form; (2) key enzymes and signaling pathways responsible for the toxicity;
and (3) effect of coexisting molecules on the toxicity and its relationship to surface coating.
Copyright ª 2014, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. Open access under CC BY-NC-ND license. 1. Introduction
Colloidal silver, silver nanoparticles, and nanosilver are some
of the names used for silver particles of 1e100 nm in at least
one of the dimensions. For convenience, we will use the
expression “nanosilver” throughout this paper for silver
nanoparticles of different shapes, sizes, and surface coatings.
Having been used as an antibiotic since ancient times, silver
has found many more applications in medicine, optics,istry and Biochemistry, J
. Yu).
ministration, Taiwan. Publsensing, painting, and cosmetics, due to the discovery of its
many properties in the nanometer-sized form [1e4]. As of
today, the Project on Emerging Nanotechnologies at the
WoodrowWilson International Center for Scholars has found
a list of more than 400 consumer products that claim to
contain nanosilver [5]. Given the increasing use in commercial
products, the potential for the release of nanosilver into the
environment and its effects on environmental health are of
increasing concern [3,6e14].ackson State University, 1400 J. R. Lynch Street, Jackson, MS 39217,
ished by Elsevier Taiwan LLC.Open access under CC BY-NC-ND license. 
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silver is argyria, although themechanism causing the lesion is
still unknown [1,3,10,14e16]. People applying nanosilver
developed bluish-colored skin. Other studies have widely
investigated toxicities such as oxidative damage in cellular
systems [17e26]. In the past 10 years, particularly the past
3 years, a great number of articles have been published in an
attempt to understand various aspects of the toxicity of
nanosilver. Several reviews have also dealt with the exposure,
environmental fate, and in vivo and in vitro toxicities
[1,3,9,10,13,14,16,27e29]. Nanosilver undergoes a variety of
transformations in environmental and biological media
[1,3,6e14,24,27,28,30e53]. The environmental fate, state of
agglomeration or aggregation, and dissolution in environ-
mental and biologicalmedia are dependent on hownanosilver
is prepared, what types of surface coating are used, and the
conditions under which they are used. As a result, environ-
mental fate is highly variable within a range of surface func-
tionalizations that canmake the samematerial biocompatible
or biohazardous. Also, a wide variety of test systems using
bacteria, cells, aquatic species, or rodents have been used to
test the toxicity of nanosilver.
This review does not intend to provide details about the
toxicity of silver nanomaterials, but will summarize some of
the more recent findings and raise questions for future
research on what is important for the understanding of the
molecular toxicity mechanism of nanosilver.2. Behavior of nanosilver in biological and
environmental media
The main changes that nanosilver undergoes in environ-
mental and biological media are as follows. (1) Losing and
displacing of the surface-coating agent. Nanosilver surface-
coating agents, such as citric acid, amino acids, cetyl trime-
thylammonium bromide, and sodium dodecyl sulfate, are
noncovalently attached to nanosilver particles, with some
beingmore tightly bound than others. These surface-attached
coating agents are in an equilibrium state with the free ligand
molecules in solution. Dispersion of nanosilver in a biological
or environmental medium will cause the surface-coating
agents to re-establish equilibrium by mostly losing some of
the coating molecules. Some will be displaced by other avail-
able molecules such as biological macromolecules, inorganic
and organic ions, or the nanosilver particles become partially
uncoated due to the lack of proper coating agents present. As a
result, nanosilver becomes unstable in these media. (2)Fig. 1 e Fate and toxicity of nanosilver inAggregation and agglomeration. Due to displacement of the
coating agents by other molecules such as water or inorganic
ions, nanosilver may no longer be stable by itself, but undergo
aggregation. This has been observed and reported in many
publications [12,20,31,32,36,43,54]. (3) Surface oxidation and
release of Agþ. Silver atoms (Ag0) on the surface of nanosilver,
when interacting with molecular oxygen, can be oxidized to
silver oxide [9,12,26,30,35,37,52,54e60]. It may also interact
with other redox-active compounds to yield ionic silver. The
silver oxide can interact with the media to release Agþ. The
oxidation to silver oxide and release of silver ions can occur in
the environmental media, biological media, as well as inside
the cell. Thus, nanosilver, whether as individual particles or as
agglomerates/aggregates, can also be viewed as a source of
Agþ through the slow-release process. These phenomena are
summarized in Fig. 1.
Levard et al [7] have recently reviewed the environmental
fate and transformation of nanosilver. They have proposed a
mechanism for the transformation of nanosilver in the envi-
ronment (Fig. 2). Other studies have also pointed out that the
transformation of nanosilver in environmental and biological
media is strongly influenced by the concentration of sulfur
ions (S2 and SH) and sulfur-containing compounds, dis-
solved oxygen, Cl, biological macromolecules (DNA and
protein), other organic compounds that have strong affinity
for either atomic or ionic silver, and lighting conditions
[6e8,10,33,38,52,54,61e66]. Among SO4
2, S2, Cl, PO43, and
EDTA, sulfide ligands are the most effective to reduce nano-
silver toxicity by formation of AgxSy [67]. Liu et al [64] have
found that nanosilver forms Ag2S by reacting with dissolved
sulfide species (H2S, HS
) under relevant, but controlled lab-
oratory conditions. The reaction kinetics and mechanism are
dependent on dissolved oxygen, pH, lighting conditions, other
organic matters, as well as the high or low concentrations of
sulfide. Exposure to light can also alter the toxicity of nano-
silver, presumably by light-induced transformation of nano-
silver [32,68].3. Mechanism of toxicity
The toxicity of nanosilver is closely related to its trans-
formation in biological and environmental media, including
surface oxidation, release of silver ions, and interaction with
biologicalmacromolecules [3,9,10,13,14,27,28]. There is always
a challenge to distinguish precisely what portion of the
toxicity is from the ionic form and what portion is from the
nano-form of silver [26,57,69,70]. AshaRani et al [71,72] havebiological and environmental media.
Fig. 2 e Proposed mechanism of environmental transformation of nanosilver. Note. From “Environmental transformations
of silver nanoparticles: impact on stability and toxicity,” by C. Levard, E.M. Hotze, G.V. Lowry, et al, 2012, Environ Sci Technol,
46, p. 6900e14. Copyright 2012, American Chemical Society. Reproduced with permission.
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posed a mechanism of toxicity (Fig. 3). Nanosilver particles
can interact with membrane proteins and activate signaling
pathways, leading to inhibition of cell proliferation [23,73,74].Fig. 3 e Proposed mechanism of nanosilver toxicity. Note. From
P. AshaRani, M.P. Hande, and S. Valiyaveettil, 2009, BMC Cell Bi
permission.The nanosilver particles can also enter the cell through
diffusion or endocytosis to cause mitochondrial dysfunction,
generation of reactive oxygen species (ROS), leading to dam-
age to proteins and nucleic acids inside the cell, and finally“Anti-proliferative activity of silver nanoparticles,” by
ol, 10, p.65. Copyright 2009, BMC Central. Reproduced with
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tive stress occurs when the generation of ROS exceeds the
capacity of the cellular antioxidant defense system. Depletion
of glutathione and protein-bound sulfhydryl groups and
changes in the activity of various antioxidant enzymes have
been implicated in oxidative damage [17,19,20,24,82e85]. An
important toxicity mechanism for nanosilver is the interac-
tion of both the ionic and nano-form of silver with sulfur-
containing macromolecules such as proteins, due to the
strong affinity of silver for sulfur [38,55,62,64,67,71,86e93].
Mitochondria appear to be the sensitive targets for nano-
silver. Bressan et al [76] have studied the interaction of nano-
silver with human dermal fibroblasts. They have found that
nanosilver particles accumulate outside the mitochondria,
cause direct mitochondrial damage, and disturb the function
of the respiratory chain, resulting in ROS generation and
oxidative stress. AshaRani et al [94] have suggested that the
disruption of the mitochondrial respiratory chain by nano-
silver increases ROS production and interruption of ATP syn-
thesis, thus leading toDNAdamage.Hsinet al [88]have studied
the toxicity mechanism of nanosilver in NIH3T3 fibroblasts.
They have found that treatment with nanosilver induces the
release of cytochrome c into the cytosol and translocation of
Bax to the mitochondria, indicating that nanosilver acts
through ROS and C-Jun N-terminal kinase to induce apoptosis
via the mitochondrial pathway. Interaction of nanosilver with
DNA also leads to cell cycle arrest at the G2/M phase. Park et al
[87] have found that nanosilver induces G1 arrest and
completely blocks the S phase, therefore inducing apoptosis.4. Interaction and damage to cell
membranes
Nanosilver can interact with cellular membranes and cause
toxicity. In particular, nanosilver can interact with bacterial
membranes and this is considered to be the main mechanism
for the antimicrobial effect of nanosilver [16,34,36,95e97].
Khan et al [95,96] have studied the interaction of nanosilver
with five types of bacteria. They have found that the adsorp-
tion of nanosilver on the bacterial surface, or interaction with
extracellular proteins, is dependent on pH, z potential, and
NaCl concentration. El Badawy et al [34] have found that sur-
face charge is the most important factor for nano-
silverebacteria interaction. Joshi et al [36] have demonstrated
that production of the extracellular polymeric substance,
colanic acid by Escherichia coli, protects the bacteria against
nanosilver toxicity. Wigginton et al [92] have found that the
binding of nanosilver to bacterial proteins inhibits enzyme
activities, and the binding is dependent on surface modifica-
tions. Grigor’Eva et al [98] have found that nanosilver particles
are adsorbed on the outer membrane of Gram-negative Sal-
monella typhimurium and the cell wall of Gram-positive Staph-
ylococcus aureus, and penetrate and accumulate in cells
without aggregation and damage of neighboring cytoplasm. In
S. aureus, nanosilver binds to DNA fibers. Cell responses to
nanosilver differ morphologically in S. typhimurium and
S. aureus, and mainly are presented by damage of cell struc-
tures. It is evident that nanosilver directly interacts withmacromolecular structures of living cells and exerts an active
influence on their metabolism.
Nanosilver interaction with mammalian cells in vitro may
cause membrane damage including altering membrane
permeability. Cheng et al [83] have found that nanosilver
disrupts cell membranes and causes apoptosis through
oxidative damage. The damage in fibroblast membranes al-
lows calcium influx and induces intracellular calcium over-
load, and further causes ROS overproduction and
mitochondrial membrane potential variation [83]. Baruwati
et al [18] have studied “green” synthesized nanosilver and
found that exposure to these particles alters the membrane
permeability of barrier cells (intestinal and brain endothelial)
and stimulates oxidative stress pathways in neurons. George
et al [35] have found cell membrane lysis in RT-W1 cells, as
well as red blood cells, upon exposure to nanosilver. Chair-
uangkitti et al [78] have found that nanosilver (< 100 nm)
causes ROS formation in A549 cells, and reduces cell viability
and mitochondrial membrane potential.5. Cellular uptake
Nanosilver can be taken up by many different cells and
become internalized [19,20,28,43,45,79,84,99e102]. Lu et al [99]
have reported that nanosilver uptake by human skin kerati-
nocytes is dependent on the size and shape of the nano-
particles and incubation time. Both spherical and rod-formed
nanosilver can penetrate the cell and the cellular uptake is
dependent on incubation time (Fig. 4).
Recent studies conducted by Kruszewski et al [28,103] have
investigated the influence of nanosilver on three mammalian
cell lines: human hepatocellular liver carcinoma (HepG2),
human lung carcinoma (A549), and human colorectal adeno-
carcinoma (HT-29). All cells were treated with 20-nm or 200-
nm nanosilver for 2 hours or 24 hours at 10 mg/mL, 50 mg/mL,
and 100 mg/mL, respectively. It has been revealed that nano-
silver uptake corresponds to the formation of ROS. Nanosilver
uptake in HT29 is lower than in A540 and HepG2 cells, indi-
cating increased ROS production in cells with higher nano-
silver uptake. This group believes that possible production of
mucin by HT29 cells might prevent the nanosilver uptake.
In experiments conducted by Monteiro-Riviere et al [104],
human epidermal keratinocytes (HEKs) were used to study
uptake of nanosilver and silica-coated nanosilver complexed
to albumin, immunoglobulin G (IgG), and transferrin human
serum proteins. Uptake of nanosilver in HEKs was < 4.1% of
the applied dose. The presence of proteins suppressed citrate,
but not silica-coated nanosilver uptake. Exposure to IgG
reduced 110-nm citrate nanosilver uptake. In contrast, the
greatest uptake of 20-nm silica nanosilver was seen with IgG,
whereas 110-nm-silica-coated nanosilver showed minimal
effect by the presence of a protein. Electron microscopy has
confirmed the cellular uptake of all nanoparticles, but has
shown differences in the appearance and agglomeration state
of the nanosilver within HEK vacuoles. This suggests that
nanosilver associated with different serum proteins forms
different protein coronas. Haase et al [19] have found that
nanosilver is mainly taken up by astrocytes, but not by neu-
rons. Yu et al [101] have recently developed a Triton-X-114-
Fig. 4 e Uptake of nanosilver by skin keratinocytes. (A) 60 nm 3 30 nm nanorod. (B) 60 nm nanosphere. (C) uptake related to
incubation time. Note. From “Effect of surface coating on the toxicity of silver nanomaterials on human skin keratinocytes,”
by W. Lu, D. Senapati, S. Wang, et al, 2010, Chem Phys Lett, 487, p. 92e6. Copyright 2010. Elsevier B.V. Reproduced with
permission.
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versus Agþ uptake in HepG2 cells. They found thatw10.3% of
the silver taken up by the cellswas in ionic form.Miao et al [84]
have reported that nanosilver can be taken up by the fresh-
water alga Ochromonas danica, and they have suggested that
the internalization of nanosilver is an alternative mechanism
of toxicity in algae. Meyer et al [43] have observed that nano-
silver can be taken up by Caenorhabditis elegans, and the
resulting toxicity due to exposure to nanosilver is from both
the internalized nanosilver particles and the ionic silver
formed outside the organism. Choi and Hu [79] have found
that the smaller 5-nmnanosilver ismore toxic to the nitrifying
bacteria than the larger particles. They have suggested that
the observed toxicity is due to easy penetration and inter-
nalization of the smaller nanoparticles.6. ROS production and cytotoxicity
Cytotoxicity of nanosilver is closely related to cellular uptake,
production of ROS, and triggering of the cellular antioxidantmechanisms [17e26,28,35,42,43,45,82e85,100e103,105,106].
Most of these studies used mammalian cells in culture
[19,83,85,103,106], but some used aquatic species [24,25,35,42]
and organisms [20e23,26,43,45]. One in vivo study by Ahmadi
et al [82] using chickens exposed to nanosilver found that
nanosilver has significant effect on the activity of oxidative
stress enzymes.
In vitro studies with various primary cells and cell lines are
the most used methods. Arora et al [107] have studied the
toxicity of nanosilver in primary fibroblast and liver cells, and
found that nanosilver is present in the mitochondria and
triggers the antioxidant mechanisms. Braydich-Strolle et al
[73] used mouse stem cells and found that smaller nanosilver
particles are more likely to produce ROS and cause apoptosis.
Trickler et al [108] have found that the cytotoxicity of poly-
vinylpyrrolidone (PVP)-coated nanosilver in rat brain cells is
size- and shape-dependent and causes proinflammatory ef-
fects. Hussain et al [105] have evaluated in vitro toxicity of
several nanoparticles, including nanosilver (15 nm and
100 nm) in a rat liver-derived cell line (BRL 3A). Following 24
hours of incubation after exposure, the mitochondrial
j o u r n a l o f f o o d and d ru g an a l y s i s 2 2 ( 2 0 1 4 ) 1 1 6e1 2 7 121function and membrane integrity (measured as lactate dehy-
drogenase leakage) were significantly decreased at 5 mg/mL
and 10 mg/ mL. Lactate dehydrogenase leakage was dose-
dependent and more severe with the 100-nm than with the
15-nm nanosilver. Several publications suggest that a strong
correlation between ROS levels and mitochondria damage
exists [14,19,20,54,69,78,109,110].7. Interaction with and damage to cellular
proteins
It is well known that silver, both nanosilver and Agþ, can
interact with proteins and amino acids. Amino acids like
cysteine have been widely used as surface-coating agents for
nanosilver [35,78]. The interaction of nanosilver with proteins
is believed to be an important mechanism of toxicity for
nanosilver [9,19,23,24,29,50,78,86,90e92,96,106,110e121]. As
proposed by Saptarshi et al [118], nanosilver can cause the
formation of protein corona, protein unfolding, and altered
protein function (Fig. 5).
Shannahan et al [119] have investigated the formation of
protein corona by incubating Dulbecco’s Modified Eagle’s
Medium supplemented with 10% fetal bovine serum and
20 nm or 110 nm citrate and PVP stabilized nanosilver for 24
hours. They found that albumin, apolipoproteins, keratins,
and other serum proteins interacted with nanosilver. Citrate-
and PVP-stabilized larger nanosilver (110 nm) showed greater
binding ability to proteins compared to smaller nanoparticles,
suggesting changes in nanoparticle size cause different pro-
tein corona formation. Corona formation found on 20 nmFig. 5 e Schematic representation of nanoparticle surface induc
consequences. Note. From “Interaction of nanoparticles with pro
Saptarshi, L. Duschl, and A.L. Lopata, 2013, J Nanobiotech, 11, p.
permission.nanosilver implies binding of more hydrophobic proteins
compared to larger 110 nm particles.
Interaction of nanosilver with protein molecules such as
serum albumin [91,113], human blood protein hemoglobin
(Hb) [65], and cytoskeletal proteins [121] has been studied
using spectroscopic methods. All these proteins interact with
nanosilver and, as a result, cause protein conformational
changes or even protein damage. The interaction with protein
is concentration dependent [86]. Nanosilver interaction with
human serum albumin induces conformational changes [113].
The percent of a helices is reduced, whereas the percent of b
sheets is increased in the human serum albumin secondary
structures. This is possibly due to breaking of the hydrogen
bonds between neighboring a helices and formation of steri-
cally less-ordered hydrogen bonds between the a helices and
the citrate-coated nanosilver. Due to the binding with bovine
serum albumin (BSA), the effectiveness of nanosilver as an
antimicrobial agent decreases [114]. Mahato et al [65] have
reported findings on the interaction of nanosilver with he-
moglobin (Hb). A time- and concentration-dependent nano-
silver interaction with Hb has been observed. Nanosilver can
bind and approach the heme, tryptophan, amide, and aro-
matic amine residues in the protein. As a result, Hb undergoes
conformational changes and becomes unfolded by increasing
the b-sheet structure. The nanosilvereHb forms a charge-
transfer complex in which the Hb heme, along with the
nanosilver involved in the electron transfer mechanism,
forms the Hbenanosilver assembled structure. The electron
transfer mechanism is dependent on the size of the silver
particles. Da Silva Paula et al [122] have found that nanosilver
in vitro inhibits creatine kinase from the brain and skeletaled unfolding of the interacting protein molecule and
teins: relation to bio-reactivity of the nanoparticle,” by S.R.
26. Copyright 2013, BMC Central. Reproduced with
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that nanosilver inhibits this enzyme through interactions
with thiol groups.
Mariam et al [123] studied the interaction between nano-
silver and BSA at physiological pH in an aqueous solution.
Fluorescence spectroscopy was used because BSA has two
fluorescent tryptophan residues. It showed that nanosilver
had a strong ability to quench the intrinsic fluorescence of
BSA by both static and dynamic quenching mechanisms. This
indicates a complex formation between BSA and nanosilver
and that spontaneous binding of BSAwith nanosilver changes
the microenvironment of the tryptophan residues in BSA.
Binding of nanosilver with bacterial proteins has also been
studied. Wigginton et al [92] have reported that binding of
nanosilver to bacterial proteins is dependent upon surface
modifications of nanosilver, and the nanosilver binding to the
bacterial protein inhibits the enzymatic activity. Nanosilver
interacts with the extracellular bacterial proteins following
pseudo-second order kinetics [96]. Joshi et al [36] have
demonstrated that production of the extracellular polymeric
substance, colanic acid by engineered E. coli protects the
bacteria against silver nanoparticle toxicity.Fig. 6 e Effect of nanosilver on 8-oxoG levels. Note. From
“Silver nanoparticles down-regulate Nrf2-mediated 8-
oxoguanine DNA glycosylase 1 through inactivation of
extracellular regulated kinase and protein kinase B in
human Chang liver cells,” by M.J. Piao, K.C. Kim, J.-Y. Choi
et al, 2011, Toxicol Lett, 207, p. 143e9. Copyright 2011,
Elsevier Ireland Ltd. Reproduced with permission.8. Binding and damage to cellular DNA and
DNA repair
Nanosilver is known to interact with DNA and cause DNA
damage. Rahban et al [124] have studied the interaction of
nanosilver with calf thymus DNA and found that nanosilver
can tightly bind DNA and alter DNA conformation. Recent
in vitro studies have investigated the ability of nanosilver to
induce DNA damage [125,126]. In the study by Hackenberg
et al [126], human mesenchymal stem cells were used to
investigate DNA damage potential. Nanosilver was found to
induce significant time-dependent DNA damage following
short exposure and incubation of 24 hours. They concluded
that, direct interaction of nanosilver may be an inducer of
genotoxicity. Inflammatory cells (neutrophils and macro-
phages) exposed to nanoparticles elicit inflammation by
forming ROS that generate oxidative DNA damage
[76,127,128]. Molecular damage in normal lung fibroblasts
(U251) and brain cancer glioblastoma (IMR-90) cells has been
examined. Nanosilver binds to cytosolic proteins causing a
corona and expresses genes involved in DNA damage.
Increased ataxia telangiectasia mutated (ATM) and ATM-
related levels in fibroblast cells indicate DNA double-strand
breakage [129]. Piao et al [85,117] have conducted a compara-
tive study with nanosilver and AgNO3 in human Chang liver
cells. They have found that nanosilver induces ROS genera-
tion, suppresses reduced glutathione, and causes DNA dam-
age, protein carbonylation, and membrane oxidation.
The main damage is the increased level of 8-oxoguanine
(Fig. 6). Similar results have been noted in a comparative
study of nanosilver and Agþ on immortalized human T
lymphocyte cells (Jurkat T) [130]. Jurkat T cells are highly
sensitive to nanosilver in that they promptly increase levels of
ROS during initial exposure. When compared to Agþ, nano-
silver causes an increase in ROS formation after 24 hours,
suggesting a slow release of silver ions to cause oxidativestress. Confirmation of oxidative stress was revealed by DNA
damage signaling pathways, p39 mitogen-activated
protein kinase, nuclear factor-E2-related factor-2, and nu-
clear factor-kB.
ROS are able to induce oxidative DNA damage and activate
a wide variety of cellular events, therefore, our group has used
both a direct DNA damage (alkaline comet assay) and an
oxidative DNA damage (formamidopyrimidine glycosylase
FPG e comet assay) method to study DNA damage and repair
(Fig. 7). Time-dependent DNA repair in human cells damaged
by nanosilver has not been reported. As shown in Fig. 7, both
time- and concentration-dependent DNA damage were
observed.
By exposing immortalized human keratinocyte cells
(HaCaT) to 10mM or 50mM nanosilver (in Ag atoms) and with
incubation times of 30minutes, 4 hours, 8 hours, and 24 hours,
a time-dependent increase of direct and oxidative DNA dam-
ages is observed (Fig. 7). The direct DNA damage increases and
reaches a maximum at 8 hours of incubation followed by a
Fig. 7 e Direct (A) and oxidative (B) DNA damage and repair
of HaCaT cells exposed to nanosilver after 30 minutes, 4
hours, 8 hours, and 24 hours of incubation.
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not reach the level of the controls (Fig. 7A). For oxidative DNA
damage, it also increases and reaches a maximum at 8 hours,
but decreases to the control level at 24 hours (Fig. 7B). We
believe that complete DNA repair is not achievable for the
direct damage because it is known that nanosilver can be
internalized in the cell and slowly release Agþ, which can
cause direct DNA damage [99,131]. This result is different from
the DNA damage and repair results when the same cell is
exposed to multiwalled carbon nanotubes (MWCNTs) as re-
ported by the authors. We found that functionalizedMWCNTs
cause increased DNA damage of HaCaT cells at up to 4 hours
(compared to 8 hours for nanosilver) [132]. Furthermore, the
damaged DNA can be fully repaired after 24 hours incubation.
This means that although both MWCNTs and nanosilver
cause DNA damage and the damage can be repaired by the
cellular repair system, the nanosilver-induced direct damage
cannot be fully repaired due to the slow release of silver ions
while inside the cells.9. Outlook
As a result of the increased use of nanosilver in consumer
products, the number of research articles on silver has beenexponentially increasing. On the toxicity of nanosilver alone,
there have been > 550 publications related to silver nano-
particle toxicity in 2011e2013, based on a search from Scopus.
com (December 15, 2013) using silver nanoparticle toxicity.
However, several key questions remain to be answered on the
toxicity mechanism of nanosilver. (1) Toxicity contribution
from the ionic form versus the nano-form of silver. Due to
surface oxidation, other surface reactions, and dissolution of
nanosilver in a biological or environmental medium, silver
ions are slowly released. It must be considered that both
contribute to the toxicity observed. It is also important to
consider some secondary products of nanosilver, such as
particles bound to protein and DNA, for their contribution to
toxicity. (2) The interaction of nanosilver with protein, nucleic
acid, and cell membrane all contributes to the toxicity of
nanosilver. However, which one is the primary biological
macromolecule that is involved in the toxicity of nanosilver?
What are the key enzymes or signaling pathways that are
involved? (3) Contribution to toxicity by coexisting molecules.
In the biological and environmental systems, there are many
coexisting molecules: inorganic ions, organic molecules, and
biological macromolecules. What are their contributions to
the toxicity of nanosilver? How does it relate to the surface
coating materials used for nanosilver?Conflicts of interest
All authors declare no conflicts of interest.
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